全文获取类型
收费全文 | 16186篇 |
免费 | 1072篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 220篇 |
儿科学 | 250篇 |
妇产科学 | 288篇 |
基础医学 | 2460篇 |
口腔科学 | 1047篇 |
临床医学 | 1518篇 |
内科学 | 3795篇 |
皮肤病学 | 395篇 |
神经病学 | 1245篇 |
特种医学 | 472篇 |
外国民族医学 | 1篇 |
外科学 | 2134篇 |
综合类 | 42篇 |
一般理论 | 8篇 |
预防医学 | 1329篇 |
眼科学 | 159篇 |
药学 | 1179篇 |
中国医学 | 150篇 |
肿瘤学 | 635篇 |
出版年
2023年 | 184篇 |
2022年 | 143篇 |
2021年 | 647篇 |
2020年 | 453篇 |
2019年 | 608篇 |
2018年 | 748篇 |
2017年 | 468篇 |
2016年 | 535篇 |
2015年 | 621篇 |
2014年 | 806篇 |
2013年 | 1014篇 |
2012年 | 1419篇 |
2011年 | 1506篇 |
2010年 | 785篇 |
2009年 | 609篇 |
2008年 | 942篇 |
2007年 | 918篇 |
2006年 | 806篇 |
2005年 | 707篇 |
2004年 | 587篇 |
2003年 | 487篇 |
2002年 | 472篇 |
2001年 | 245篇 |
2000年 | 243篇 |
1999年 | 208篇 |
1998年 | 62篇 |
1997年 | 54篇 |
1996年 | 30篇 |
1995年 | 42篇 |
1994年 | 42篇 |
1993年 | 34篇 |
1992年 | 111篇 |
1991年 | 79篇 |
1990年 | 93篇 |
1989年 | 73篇 |
1988年 | 51篇 |
1987年 | 47篇 |
1986年 | 45篇 |
1985年 | 52篇 |
1984年 | 32篇 |
1983年 | 19篇 |
1979年 | 20篇 |
1978年 | 23篇 |
1976年 | 17篇 |
1975年 | 19篇 |
1974年 | 17篇 |
1973年 | 22篇 |
1971年 | 22篇 |
1970年 | 19篇 |
1969年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Natasa Strbo Irena Pastar Laura Romero Vivien Chen Milos Vujanac Andrew P. Sawaya Ivan Jozic Andrea D. F. Ferreira Lulu L. Wong Cheyanne Head Olivera Stojadinovic Denisse Garcia Katelyn O'Neill Stefan Drakulich Seth Taller Robert S. Kirsner Marjana Tomic‐Canic 《Experimental dermatology》2019,28(3):225-232
4.
5.
6.
7.
Erika Cecon Anna Ivanova Marine Luka Florence Gbahou Anne Friederich Jean‐Luc Guillaume Patrick Keller Klaus Knoch Raise Ahmad Philippe Delagrange Michele Solimena Ralf Jockers 《Journal of pineal research》2019,66(2)
Melatonin receptors play important roles in the regulation of circadian and seasonal rhythms, sleep, retinal functions, the immune system, depression, and type 2 diabetes development. Melatonin receptors are approved drug targets for insomnia, non‐24‐hour sleep‐wake disorders, and major depressive disorders. In mammals, two melatonin receptors (MTRs) exist, MT1 and MT2, belonging to the G protein‐coupled receptor (GPCR) superfamily. Similar to most other GPCRs, reliable antibodies recognizing melatonin receptors proved to be difficult to obtain. Here, we describe the development of the first monoclonal antibodies (mABs) for mouse MT1 and MT2. Purified antibodies were extensively characterized for specific reactivity with mouse, rat, and human MT1 and MT2 by Western blot, immunoprecipitation, immunofluorescence, and proximity ligation assay. Several mABs were specific for either mouse MT1 or MT2. None of the mABs cross‐reacted with rat MTRs, and some were able to react with human MTRs. The specificity of the selected mABs was validated by immunofluorescence microscopy in three established locations (retina, suprachiasmatic nuclei, pituitary gland) for MTR expression in mice using MTR‐KO mice as control. MT2 expression was not detected in mouse insulinoma MIN6 cells or pancreatic beta‐cells. Collectively, we report the first monoclonal antibodies recognizing recombinant and native mouse melatonin receptors that will be valuable tools for future studies. 相似文献
8.
Sílvia Aguiar Rosa Pedro Silva Cunha Ana Lousinha Bruno Valente Ana Sofia Delgado Ricardo Pimenta Manuel Brás Madalena Coutinho Cruz Guilherme Portugal André Viveiros Monteiro Mário Oliveira Rui Cruz Ferreira 《Revista portuguesa de cardiologia》2019,38(1):11-16
Introduction
Implantable cardioverter-defibrillator (ICD) monitoring zones (MZ) provide passive features that do not interfere with the functioning of active treatment zones. However, it is not known for certain whether programming an MZ affects arrhythmia detection by the ICD. The aim of the present study is to assess the clinical relevance of MZ in a population of patients with ICDs.Methods
In this retrospective analysis of patients with ICDs, with or without cardiac resynchronization therapy, for primary prevention under remote monitoring, the MZ was analyzed and recorded arrhythmias were assessed in detail.Results
A total of 221 patients were studied (77% men; age 64±12 years). Mean ejection fraction was 30±12%. The mean follow-up was 63±35 months. One hundred and seventy-four MZ events were documented in 139 patients (62.9%): 74 of non-sustained ventricular tachycardia (NSVT), 42 of supraventricular tachycardia, 44 of atrial fibrillation/atrial flutter, and five cases of noise. Among the 137 patients who presented with arrhythmias in the MZ (excluding two cases with noise detection only), 22 (16.1%) received appropriate shocks and/or antitachycardia pacing (ATP), while of the other 84 patients, 15.5% received appropriate ICD treatment (p=NS). In patients who presented with NSVT in the MZ, 15 (20.5%) received appropriate shocks and/or ATP. In accordance with the MZ findings, physicians decided to change outpatient medication in 41.7% of all patients in whom arrhythmic events were reported.Conclusion
Ventricular and supraventricular arrhythmias are common findings in the MZ of ICD patients. Programming an MZ is valuable in the diagnosis of arrhythmias and may be a useful tool in clinical practice. 相似文献9.
10.
Emilie Cayssials MD Jose Torregrosa-Diaz MD Pilar Gallego-Hernanz MD Florence Tartarin MD Thomas Systchenko MD Natacha Maillard MD Déborah Desmier MD Antoine Machet MD Emmanuel Fleck MD Anne Corby MD Carine Motard MD Guillaume Denis MD André Herbelin PhD Jean-Marc Gombert MD PhD Lydia Roy MD Stéphanie Ragot PharmD PhD Xavier Leleu MD PhD François Guilhot MD Jean-Claude Chomel PharmD PhD 《Cancer》2020,126(15):3438-3447